NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

婦產科診斷市場 - 全球產業分析,規模,佔有率,成長,趨勢,預測

Women's Health Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027

出版商 Transparency Market Research 商品編碼 926721
出版日期 內容資訊 英文 204 Pages
商品交期: 最快1-2個工作天內
價格
婦產科診斷市場 - 全球產業分析,規模,佔有率,成長,趨勢,預測 Women's Health Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027
出版日期: 2020年01月14日內容資訊: 英文 204 Pages
簡介

本報告提供全球婦產科診斷市場相關調查,彙整市場趨勢與預測,市場規模,主要加入企業,各地區趨勢相關資訊。

第1章 序論

第2章 假設和調查方法

第3章 摘要整理

第4章 市場概要

  • 簡介
  • 概要
  • 市場趨勢
    • 促進要素
    • 阻礙要素
    • 機會
  • 市場分析與預測

第5章 市場分析與預測:各設備類型

  • 簡介
  • 主要調查結果
  • 市場值預測
    • 切片設備
    • 影像·監控系統
    • 套件·試劑
    • 消耗品·配件
  • 市場魅力度

第6章 市場分析與預測:檢驗各類型

  • 簡介
  • 主要調查結果
  • 市場值預測
    • 乳癌檢驗
    • 子宮頸癌檢驗
    • 新生兒遺傳基因篩檢,基因帶原檢測
    • 妊娠檢驗
    • 不孕·排卵檢驗
    • 傳染病檢查
    • 其他
  • 市場魅力度

第7章 市場分析與預測:各終端用戶

  • 簡介
  • 主要調查結果
  • 市場值預測
    • 醫院
    • 診斷測試所,影像中心
    • 專門診所
    • 其他
  • 市場魅力度

第8章 市場分析與預測:各地區

  • 主要調查結果
  • 市場值預測
    • 北美
    • 歐洲
    • 亞太地區
    • 南美
    • 中東·非洲
  • 市場魅力度分析

第9章 北美

第10章 歐洲

第11章 亞太地區

第12章 南美

第13章 中東·非洲

第14章 競爭環境

  • 市場參與企業
  • 市場佔有率分析
  • 企業簡介
目錄
Product Code: TMRGL63339

Title:
Women's Health Diagnostics Market (Device Type: Biopsy Devices, Imaging & Monitoring Systems, Kits & Reagents, and Consumables & Accessories; Test Type: Breast Cancer Testing, Cervical Cancer Testing, Prenatal Genetic Screening & Carrier Testing, Pregnancy Testing, Fertility & Ovulation Testing, Infectious Disease Testing, and Others; and End User: Hospitals, Diagnostic Laboratories & Imaging Centers, Specialty Clinics, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027.

Women's Health Diagnostics Market - Scope of the Report

TMR's report on the global women's health diagnostics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the mentioned indicators for the market during the forecast period from 2019 to 2027. The report provides the revenue of the women's health diagnostics market for the period from 2017 to 2027, considering 2018 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the women's health diagnostics market for the forecast period from 2019 to 2027.

The report has been prepared after extensive research. Primary research involved bulk of research efforts, wherein analysts conducted interviews with market leaders and opinion makers. Extensive secondary research involved studying key players' product literature, annual reports, press releases, and relevant documents to understand the women's health diagnostics market.

Secondary research also includes Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various phenomenon in the women's health diagnostics market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments in the scope of the study. Furthermore, the report sheds light on changing competitive dynamics in the women's health diagnostics market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the women's health diagnostics market.

The report delves into the competitive landscape of the women's health diagnostics market. Key players operating in the women's health diagnostics market have been identified and each one of these has been profiled for their distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT analysis are some of the attributes of players in the women's health diagnostics market profiled in this report.

Key Questions Answered in Women's Health Diagnostics Market Report

How does the development of women's health diagnostics provide the scope of growth in the women's health diagnostics market?

How alliances and partnerships between players are widening the scope of new preservation techniques for women's health diagnostics?

What are the revenue share projections of key segments under various criteria in the women's health diagnostics market during the forecast period?

Which segment is likely to generate the highest revenue by the end of the forecast period in 2027?

How is the evolving healthcare system in developing countries in Asia Pacific making an impact on the overall women's health diagnostics market?

Women's Health Diagnostics Market - Research Objectives and Research Approach

The comprehensive report on the women's health diagnostics market begins with an overview section, followed by the scope and objectives of the study. Following this, the report provides detailed explanation of the objectives of the study and healthcare compliances laid down by accredited agencies in the purview of line of procedure for women's health diagnostics.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section further divided into small sections. The entire report comprises an exhaustive collection of graphs and tables that are appropriately interspersed in the entire compilation. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of market shares of key segments in the past and at the end of the forecast period.

The report analyzes the women's health diagnostics market in terms of device type, test type, end user, and region. Key segments under each criteria have been studied at length and the market share for each of these at the end of 2027 has also provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the women's health diagnostics market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. 3. Executive Summary: Global Women's Health Diagnostics Market

4. Market Overview

  • 4.1. Introduction
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Women's Health Diagnostics Market Analysis and Forecast, 2017-2027
    • 4.4.1. Market Revenue Projections (US$ Mn)

5. Global Women's Health Diagnostics Market Analysis and Forecast, by Device Type

  • 5.1. Introduction
  • 5.2. Key Findings
  • 5.3. Global Women's Health Diagnostics Market Value Forecast, by Device Type, 2017-2027
    • 5.3.1. Biopsy Devices
    • 5.3.2. Imaging & Monitoring System
      • 5.3.2.1. Ultrasound Devices
      • 5.3.2.2. Mammography Systems
      • 5.3.2.3. MRI Systems
      • 5.3.2.4. Others
    • 5.3.3. Kits & Reagents
    • 5.3.4. Consumables & Accessories
  • 5.4. Global Women's Health Diagnostics Market Attractiveness, by Device Type

6. Global Women's Health Diagnostics Market Analysis and Forecast, by Test Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings
  • 6.3. Global Women's Health Diagnostics Market Value Forecast, by Test Type, 2017-2027
    • 6.3.1. Breast Cancer Testing
    • 6.3.2. Cervical Cancer Testing
    • 6.3.3. Prenatal Genetic Screening & Carrier Testing
    • 6.3.4. Pregnancy Testing
    • 6.3.5. Fertility & Ovulation Testing
    • 6.3.6. Infectious Disease Testing
    • 6.3.7. Others
  • 6.4. Global Women's Health Diagnostics Market Attractiveness, by Test Type

7. Global Women's Health Diagnostics Market Analysis and Forecast, by End-user

  • 7.1. Introduction
  • 7.2. Key Findings
  • 7.3. Global Women's Health Diagnostics Market Value Forecast, by End-user, 2017-2027
    • 7.3.1. Hospitals
    • 7.3.2. Diagnostic Laboratories & Imaging Centers
    • 7.3.3. Specialty Clinics
    • 7.3.4. Others
  • 7.4. Global Women's Health Diagnostics Market Attractiveness, by End-user

8. Global Women's Health Diagnostics Market Analysis and Forecast, by Region

  • 8.1. Key Findings
  • 8.2. Global Women's Health Diagnostics Market Value Forecast, by Region, 2017-2027
    • 8.2.1. North America
    • 8.2.2. Europe
    • 8.2.3. Asia Pacific
    • 8.2.4. Latin America
    • 8.2.5. Middle East & Africa
  • 8.3. Global Women's Health Diagnostics Market Attractiveness, by Region

9. North America Women's Health Diagnostics Market Analysis and Forecast

  • 9.1. Introduction
    • 9.1.1. Key Findings
  • 9.2. North America Women's Health Diagnostics Market Value Forecast, by Device Type, 2017-2027
    • 9.2.1. Biopsy Devices
    • 9.2.2. Imaging & Monitoring System
      • 9.2.2.1. Ultrasound Devices
      • 9.2.2.2. Mammography Systems
      • 9.2.2.3. MRI Systems
      • 9.2.2.4. Others
    • 9.2.3. Kits & Reagents
    • 9.2.4. Consumables & Accessories
  • 9.3. North America Women's Health Diagnostics Market Value Forecast, by Test Type, 2017-2027
    • 9.3.1. Breast Cancer Testing
    • 9.3.2. Cervical Cancer Testing
    • 9.3.3. Prenatal Genetic Screening & Carrier Testing
    • 9.3.4. Pregnancy Testing
    • 9.3.5. Fertility & Ovulation Testing
    • 9.3.6. Infectious Disease Testing
    • 9.3.7. Others
  • 9.4. North America Women's Health Diagnostics Market Value Forecast, by End-user, 2017-2027
    • 9.4.1. Hospitals
    • 9.4.2. Diagnostic Laboratories & Imaging Centers
    • 9.4.3. Specialty Clinics
    • 9.4.4. Others
  • 9.5. North America Women's Health Diagnostics Market Value Forecast, by Country, 2017-2027
    • 9.5.1. U.S.
    • 9.5.2. Canada
  • 9.6. North America Women's Health Diagnostics Market Attractiveness Analysis
    • 9.6.1. By Device Type
    • 9.6.2. By Test Type
    • 9.6.3. By End-user
    • 9.6.4. By Country

10. Europe Women's Health Diagnostics Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Europe Women's Health Diagnostics Market Value Forecast, by Device Type, 2017-2027
    • 10.2.1. Biopsy Devices
    • 10.2.2. Imaging & Monitoring System
      • 10.2.2.1. Ultrasound Devices
      • 10.2.2.2. Mammography Systems
      • 10.2.2.3. MRI Systems
      • 10.2.2.4. Others
    • 10.2.3. Kits & Reagents
    • 10.2.4. Consumables & Accessories
  • 10.3. Europe Women's Health Diagnostics Market Value Forecast, by Test Type, 2017-2027
    • 10.3.1. Breast Cancer Testing
    • 10.3.2. Cervical Cancer Testing
    • 10.3.3. Prenatal Genetic Screening & Carrier Testing
    • 10.3.4. Pregnancy Testing
    • 10.3.5. Fertility & Ovulation Testing
    • 10.3.6. Infectious Disease Testing
    • 10.3.7. Others
  • 10.4. Europe Women's Health Diagnostics Market Value Forecast, by End-user, 2017-2027
    • 10.4.1. Hospitals
    • 10.4.2. Diagnostic Laboratories & Imaging Centers
    • 10.4.3. Specialty Clinics
    • 10.4.4. Others
  • 10.5. Europe Women's Health Diagnostics Market Value Forecast, by Country/Sub-region, 2017-2027
    • 10.5.1. Germany
    • 10.5.2. U.K.
    • 10.5.3. France
    • 10.5.4. Spain
    • 10.5.5. Italy
    • 10.5.6. Rest of Europe
  • 10.6. Europe Women's Health Diagnostics Market Attractiveness Analysis
    • 10.6.1. By Device Type
    • 10.6.2. By Test Type
    • 10.6.3. By End-user
    • 10.6.4. By Country/Sub-region

11. Asia Pacific Women's Health Diagnostics Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Asia Pacific Women's Health Diagnostics Market Value Forecast, by Device Type, 2017-2027
    • 11.2.1. Biopsy Devices
    • 11.2.2. Imaging & Monitoring System
      • 11.2.2.1. Ultrasound Devices
      • 11.2.2.2. Mammography Systems
      • 11.2.2.3. MRI Systems
      • 11.2.2.4. Others
    • 11.2.3. Kits & Reagents
    • 11.2.4. Consumables & Accessories
  • 11.3. Asia Pacific Women's Health Diagnostics Market Value Forecast, by Test Type, 2017-2027
    • 11.3.1. Breast Cancer Testing
    • 11.3.2. Cervical Cancer Testing
    • 11.3.3. Prenatal Genetic Screening & Carrier Testing
    • 11.3.4. Pregnancy Testing
    • 11.3.5. Fertility & Ovulation Testing
    • 11.3.6. Infectious Disease Testing
    • 11.3.7. Others
  • 11.4. Asia Pacific Women's Health Diagnostics Market Value Forecast, by End-user, 2017-2027
    • 11.4.1. Hospitals
    • 11.4.2. Diagnostic Laboratories & Imaging Centers
    • 11.4.3. Specialty Clinics
    • 11.4.4. Others
  • 11.5. Asia Pacific Women's Health Diagnostics Market Value Forecast, by Country/Sub-region, 2017-2027
    • 11.5.1. China
    • 11.5.2. Japan
    • 11.5.3. India
    • 11.5.4. Australia & New Zealand
    • 11.5.5. Rest of Asia Pacific
  • 11.6. Asia Pacific Women's Health Diagnostics Market Attractiveness Analysis
    • 11.6.1. By Device Type
    • 11.6.2. By Test Type
    • 11.6.3. By End-user
    • 11.6.4. By Country/Sub-region

12. Latin America Women's Health Diagnostics Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Latin America Women's Health Diagnostics Market Value Forecast, by Device Type, 2017-2027
    • 12.2.1. Biopsy Devices
    • 12.2.2. Imaging & Monitoring System
      • 12.2.2.1. Ultrasound Devices
      • 12.2.2.2. Mammography Systems
      • 12.2.2.3. MRI Systems
      • 12.2.2.4. Others
    • 12.2.3. Kits & Reagents
    • 12.2.4. Consumables & Accessories
  • 12.3. Latin America Women's Health Diagnostics Market Value Forecast, by Test Type, 2017-2027
    • 12.3.1. Breast Cancer Testing
    • 12.3.2. Cervical Cancer Testing
    • 12.3.3. Prenatal Genetic Screening & Carrier Testing
    • 12.3.4. Pregnancy Testing
    • 12.3.5. Fertility & Ovulation Testing
    • 12.3.6. Infectious Disease Testing
    • 12.3.7. Others
  • 12.4. Latin America Women's Health Diagnostics Market Value Forecast, by End-user, 2017-2027
    • 12.4.1. Hospitals
    • 12.4.2. Diagnostic Laboratories & Imaging Centers
    • 12.4.3. Specialty Clinics
    • 12.4.4. Others
  • 12.5. Latin America Women's Health Diagnostics Market Attractiveness Analysis
    • 12.5.1. By Device Type
    • 12.5.2. By Test Type
    • 12.5.3. By End-user
    • 12.5.4. By Country/Sub-region

13. Middle East & Africa Women's Health Diagnostics Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Middle East & Africa Women's Health Diagnostics Market Value Forecast, by Device Type, 2017-2027
    • 13.2.1. Biopsy Devices
    • 13.2.2. Imaging & Monitoring System
      • 13.2.2.1. Ultrasound Devices
      • 13.2.2.2. Mammography Systems
      • 13.2.2.3. MRI Systems
      • 13.2.2.4. Others
    • 13.2.3. Kits & Reagents
    • 13.2.4. Consumables & Accessories
  • 13.3. Middle East & Africa Women's Health Diagnostics Market Value Forecast, by Test Type, 2017-2027
    • 13.3.1. Breast Cancer Testing
    • 13.3.2. Cervical Cancer Testing
    • 13.3.3. Prenatal Genetic Screening & Carrier Testing
    • 13.3.4. Pregnancy Testing
    • 13.3.5. Fertility & Ovulation Testing
    • 13.3.6. Infectious Disease Testing
    • 13.3.7. Others
  • 13.4. Middle East & Africa Women's Health Diagnostics Market Value Forecast, by End-user, 2017-2027
    • 13.4.1. Hospitals
    • 13.4.2. Diagnostic Laboratories & Imaging Centers
    • 13.4.3. Specialty Clinics
    • 13.4.4. Others
  • 13.5. Middle East & Africa Women's Health Diagnostics Market Value Forecast, by Country/Sub-region, 2017-2027
    • 13.5.1. GCC Countries
    • 13.5.2. South Africa
    • 13.5.3. Rest of Middle East & Africa
  • 13.6. Middle East & Africa Women's Health Diagnostics Market Attractiveness Analysis
    • 13.6.1. By Device Type
    • 13.6.2. By Test Type
    • 13.6.3. By End-user
    • 13.6.4. By Country/Sub-region

14. Competition Landscape

  • 14.1. Market Players - Competition Matrix (By Tier and Size of companies)
  • 14.2. Market Share Analysis, by Company, 2018
  • 14.3. Company Profiles
    • 14.3.1. Abbott Laboratories
      • 14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.1.2. Financial Overview
      • 14.3.1.3. Product Portfolio
      • 14.3.1.4. SWOT Analysis
      • 14.3.1.5. Strategic Overview
    • 14.3.2. Becton, Dickinson and Company
      • 14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.2.2. Financial Overview
      • 14.3.2.3. Product Portfolio
      • 14.3.2.4. SWOT Analysis
      • 14.3.2.5. Strategic Overview
    • 14.3.3. bioMerieux SA
      • 14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.3.2. Financial Overview
      • 14.3.3.3. Product Portfolio
      • 14.3.3.4. SWOT Analysis
      • 14.3.3.5. Strategic Overview
    • 14.3.4. F. Hoffmann-La Roche AG
      • 14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.4.2. Financial Overview
      • 14.3.4.3. Product Portfolio
      • 14.3.4.4. SWOT Analysis
      • 14.3.4.5. Strategic Overview
    • 14.3.5. GE Healthcare
      • 14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.5.2. Financial Overview
      • 14.3.5.3. Product Portfolio
      • 14.3.5.4. SWOT Analysis
      • 14.3.5.5. Strategic Overview
    • 14.3.6. Hologic, Inc.
      • 14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.6.2. Financial Overview
      • 14.3.6.3. Product Portfolio
      • 14.3.6.4. SWOT Analysis
      • 14.3.6.5. Strategic Overview
    • 14.3.7. Koninklijke Philips N.V.
      • 14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.7.2. Financial Overview
      • 14.3.7.3. Product Portfolio
      • 14.3.7.4. SWOT Analysis
      • 14.3.7.5. Strategic Overview
    • 14.3.8. Quest Diagnostics, Inc.
      • 14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.8.2. Financial Overview
      • 14.3.8.3. Product Portfolio
      • 14.3.8.4. SWOT Analysis
      • 14.3.8.5. Strategic Overview
    • 14.3.9. Cardinal Health
      • 14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.9.2. Financial Overview
      • 14.3.9.3. Product Portfolio
      • 14.3.9.4. SWOT Analysis
      • 14.3.9.5. Strategic Overview
    • 14.3.10. Siemens AG
      • 14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.10.2. Financial Overview
      • 14.3.10.3. Product Portfolio
      • 14.3.10.4. SWOT Analysis
      • 14.3.10.5. Strategic Overview

List of Tables

  • Table 01: Global Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Device Type, 2017-2027
  • Table 02: Global Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Imaging and Monitoring Systems, 2017-2027
  • Table 03: Global Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017-2027
  • Table 04: Global Women's Health Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2027
  • Table 05: Global Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Region, 2017-2027
  • Table 06: North America Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Country, 2017-2027
  • Table 07: North America Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Device Type, 2017-2027
  • Table 08: North America Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Imaging and Monitoring System
  • Table 09: North America Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017-2027
  • Table 10: North America Women's Health Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2027
  • Table 11: Europe Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
  • Table 12: Europe Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Device Type, 2017-2027
  • Table 13: Europe Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Imaging and Monitoring System
  • Table 14: Europe Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017-2027
  • Table 15: Europe Women's Health Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2027
  • Table 16: Asia Pacific Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
  • Table 17: Asia Pacific Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Device Type, 2017-2027
  • Table 18: Asia Pacific Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Imaging and Monitoring System
  • Table 19: Asia Pacific Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017-2027
  • Table 20: Asia Pacific Women's Health Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2027
  • Table 21: Latin America Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
  • Table 22: Latin America Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Device Type, 2017-2027
  • Table 23: Latin America Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Imaging and Monitoring System
  • Table 24: Latin America Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017-2027
  • Table 25: Latin America Women's Health Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2027
  • Table 26: Middle East & Africa Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
  • Table 27: Middle East & Africa Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Device Type, 2017-2027
  • Table 28: Middle East & Africa Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Imaging and Monitoring System
  • Table 29: Middle East & Africa Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017-2027
  • Table 30: Middle East & Africa Women's Health Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2027

List of Figures

  • Figure 01: Global Women's Health Diagnostics Market Value (US$ Mn) Forecast, 2017-2027
  • Figure 02: Global Women's Health Diagnostics Market Value Share by Device Type (2018)
  • Figure 03: Global Women's Health Diagnostics Market Value Share by End-users (2018)
  • Figure 04: Global Women's Health Diagnostics Market Value Share by Test Type (2018)
  • Figure 05: Global Women's Health Diagnostics Market Value Share by Region (2018)
  • Figure 06: Global Women's Health Diagnostics Market Value Share, by Device Type, 2018 and 2027
  • Figure 07: Global Women's Health Diagnostics Market Attractiveness, by Device Type, 2018
  • Figure 08: Global Women's Health Diagnostics Market Value (US$ Mn) and Y-o-Y Growth (%), by Biopsy Devices, 2017-2027
  • Figure 09: Global Women's Health Diagnostics Market Value (US$ Mn) and Y-o-Y Growth (%), by Imaging and Monitoring Systems, 2017-2027
  • Figure 10: Global Women's Health Diagnostics Market Value (US$ Mn) and Y-o-Y Growth (%), by Kits & Reagents, 2017-2027
  • Figure 11: Global Women's Health Diagnostics Market Value (US$ Mn) and Y-o-Y Growth (%), by Consumables & Accessories, 2017-2027
  • Figure 12: Global Women's Health Diagnostics Market Value Share Analysis, by Test Type, 2018 and 2027
  • Figure 13: Global Women's Health Diagnostics Market Attractiveness Analysis, by Test Type, 2018
  • Figure 14: Global Women's Health Diagnostics Market Value (US$ Mn) and Y-o-Y Growth (%), by Breast Cancer Testing, 2017-2027
  • Figure 15: Global Women's Health Diagnostics Market Value (US$ Mn) and Y-o-Y Growth (%), by Cervical Cancer Testing, 2017- 2027
  • Figure 16: Global Women's Health Diagnostics Market Value (US$ Mn) and Y-o-Y Growth (%), by Prenatal Genetic Screening and Carrier Testing, 2017-2027
  • Figure 17: Global Women's Health Diagnostics Market Value (US$ Mn) and Y-o-Y Growth (%), by Pregnancy Testing, 2017- 2027
  • Figure 18: Global Women's Health Diagnostics Market Value (US$ Mn) and Y-o-Y Growth (%), by Fertility and Ovulation Testing, 2017-2027
  • Figure 19: Global Women's Health Diagnostics Market Value (US$ Mn) and Y-o-Y Growth (%), by Infectious Disease Testing, 2017- 2027
  • Figure 20: Global Women's Health Diagnostics Market Value (US$ Mn) and Y-o-Y Growth (%), by Others, 2017-2027
  • Figure 21: Global Women's Health Diagnostics Market Value Share Analysis, by End-user, 2018 and 2027
  • Figure 22: Global Women's Health Diagnostics Market Attractiveness Analysis, by End-user, 2018
  • Figure 23: Global Women's Health Diagnostics Market Value (US$ Mn) and Y-o-Y Growth (%), by Hospitals, 2017-2027
  • Figure 24: Global Women's Health Diagnostics Market Value (US$ Mn) and Y-o-Y Growth (%), by Diagnostic Laboratories & Imaging Centers, 2017-2027
  • Figure 25: Global Women's Health Diagnostics Market Value (US$ Mn) and Y-o-Y Growth (%), by Specialty Clinics, 2017-2027
  • Figure 26: Global Women's Health Diagnostics Market Value (US$ Mn) and Y-o-Y Growth (%), by Others, 2017-2027
  • Figure 27: Global Women's Health Diagnostics Market Value Share Analysis, by Region, 2018 and 2027
  • Figure 28: Global Women's Health Diagnostics Market Attractiveness Analysis, by Region, 2018
  • Figure 29: North America Women's Health Diagnostics Market Value (US$ Mn) Forecast, 2017-2027
  • Figure 30: North America Women's Health Diagnostics Market Attractiveness Analysis, by Country, 2018
  • Figure 31: North America Women's Health Diagnostics Market Value Share Analysis, by Country, 2018 and 2027
  • Figure 32: North America Women's Health Diagnostics Market Value Share Analysis, by Device Type, 2018 and 2027
  • Figure 33: North America Women's Health Diagnostics Market Attractiveness, by Device Type, 2018
  • Figure 34: North America Women's Health Diagnostics Market Value Share Analysis, by Test Type, 2018 and 2027
  • Figure 35: North America Women's Health Diagnostics Market Attractiveness Analysis, by Test Type, 2018
  • Figure 36: North America Women's Health Diagnostics Market Value Share Analysis, by End-user, 2018 and 2027
  • Figure 37: North America Women's Health Diagnostics Market Attractiveness Analysis, by End-user, 2018
  • Figure 38: Europe Women's Health Diagnostics Market Value (US$ Mn) Forecast, 2017-2027
  • Figure 39: Europe Women's Health Diagnostics Market Attractiveness, by Country/Sub-region, 2018
  • Figure 40: Europe Women's Health Diagnostics Market Value Share, by Country/Sub-region, 2018 and 2027
  • Figure 41: Europe Women's Health Diagnostics Market Value Share Analysis, by Device Type, 2018 and 2027
  • Figure 42: Europe Women's Health Diagnostics Market Attractiveness, by Device Type, 2018
  • Figure 43: Europe Women's Health Diagnostics Market Value Share Analysis, by Test Type, 2018 and 2027
  • Figure 44: Europe Women's Health Diagnostics Market Attractiveness Analysis, by Test Type, 2018
  • Figure 45: Europe Women's Health Diagnostics Market Value Share Analysis, by End-user, 2018 and 2027
  • Figure 46: Europe Women's Health Diagnostics Market Attractiveness Analysis, by End-user, 2018
  • Figure 47: Asia Pacific Women's Health Diagnostics Market Value (US$ Mn) Forecast, 2017-2027
  • Figure 48: Asia Pacific Women's Health Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2018
  • Figure 49: Asia Pacific Women's Health Diagnostics Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
  • Figure 50: Asia Pacific Women's Health Diagnostics Market Value Share Analysis, by Device Type, 2018 and 2027
  • Figure 51: Asia Pacific Women's Health Diagnostics Market Attractiveness, by Device Type, 2018
  • Figure 52: Asia Pacific Women's Health Diagnostics Market Value Share Analysis, by Test Type, 2018 and 2027
  • Figure 53: Asia Pacific Women's Health Diagnostics Market Attractiveness Analysis, by Test Type, 2018
  • Figure 54: Asia Pacific Women's Health Diagnostics Market Value Share Analysis, by End-user, 2018 and 2027
  • Figure 55: Asia Pacific Women's Health Diagnostics Market Attractiveness Analysis, by End-user, 2018
  • Figure 56: Latin America Women's Health Diagnostics Market Value (US$ Mn) Forecast, 2017-2027
  • Figure 57: Latin America Women's Health Diagnostics Market Attractiveness, by Country/Sub-region, 2018
  • Figure 58: Latin America Women's Health Diagnostics Market Value Share, by Country/Sub-region, 2018 and 2027
  • Figure 59: Latin America Women's Health Diagnostics Market Value Share Analysis, by Device Type, 2018 and 2027
  • Figure 60: Latin America Women's Health Diagnostics Market Attractiveness, by Device Type, 2018
  • Figure 61: Latin America Women's Health Diagnostics Market Value Share Analysis, by Test Type, 2018 and 2027
  • Figure 62: Latin America Women's Health Diagnostics Market Attractiveness Analysis, by Test Type, 2018
  • Figure 63: Latin America Women's Health Diagnostics Market Value Share Analysis, by End-user, 2018 and 2027
  • Figure 64: Latin America Women's Health Diagnostics Market Attractiveness Analysis, by End-user, 2018
  • Figure 65: Middle East & Africa Women's Health Diagnostics Market Value (US$ Mn) Forecast, 2017-2027
  • Figure 66: Middle East & Africa Women's Health Diagnostics Market Attractiveness, by Country/Sub-region, 2018
  • Figure 67: Middle East & Africa Women's Health Diagnostics Market Value Share, by Country/Sub-region, 2018 and 2027
  • Figure 68: Middle East & Africa Women's Health Diagnostics Market Value Share Analysis, by Device Type, 2018 and 2027
  • Figure 69: Middle East & Africa Women's Health Diagnostics Market Attractiveness, by Device Type, 2018
  • Figure 70: Middle East & Africa Women's Health Diagnostics Market Value Share Analysis, by Test Type, 2018 and 2027
  • Figure 71: Middle East & Africa Women's Health Diagnostics Market Attractiveness Analysis, by Test Type, 2018
  • Figure 72: Middle East & Africa Women's Health Diagnostics Market Value Share Analysis, by End-user, 2018 and 2027
  • Figure 73: Middle East & Africa Women's Health Diagnostics Market Attractiveness Analysis, by End-user, 2018
  • Figure 74: Global Women's Health Diagnostics Market Share Analysis, by Company (2018)